Caption Management, LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
Caption Management, LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,970,000
-12.6%
120,0000.0%0.05%
-23.3%
Q2 2023$3,398,400
+29.7%
120,000
+5.2%
0.06%
+17.6%
Q1 2023$2,620,555
+55.5%
114,086
+90.1%
0.05%
+96.2%
Q4 2022$1,684,800
-58.9%
60,000
-58.6%
0.03%
-54.4%
Q3 2022$4,100,000
-8.6%
145,000
-5.8%
0.06%
+5.6%
Q1 2022$4,484,000
+4.1%
154,000
+17.6%
0.05%
+12.5%
Q4 2021$4,308,000
-34.3%
131,000
+10.1%
0.05%
-44.2%
Q2 2021$6,560,000
+62.9%
119,000
+52.6%
0.09%
-1.1%
Q1 2021$4,028,000
-4.2%
78,000
-19.6%
0.09%
-9.4%
Q4 2020$4,204,000
+13.2%
97,000
-8.5%
0.10%
+11.6%
Q3 2020$3,713,000
-34.5%
106,0000.0%0.09%
-54.5%
Q2 2020$5,671,000
+188.2%
106,000
+91.0%
0.19%
+70.3%
Q1 2020$1,968,000
-43.9%
55,500
-24.5%
0.11%
-5.9%
Q4 2019$3,508,000
-68.7%
73,500
-78.7%
0.12%
-79.8%
Q3 2019$11,194,000345,6000.58%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,930,369$118,428,00083.56%
Third Rock Ventures, LLC 3,070,090$188,350,00021.97%
Opaleye Management Inc. 113,500$6,963,225,0005.43%
BB BIOTECH AG 1,890,521$115,983,0004.72%
Eventide Asset Management 431,600$26,479,0003.70%
Atika Capital Management LLC 54,000$3,313,0002.55%
Cormorant Asset Management, LP 100,000$6,135,0001.26%
BRIDGER MANAGEMENT, LLC 220,099$13,503,0000.92%
Ghost Tree Capital, LLC 20,000$1,227,0000.67%
HAMILTON LANE ADVISORS LLC 27,544$1,690,0000.55%
View complete list of AGIOS PHARMACEUTICALS INC shareholders